Nov 20, 2025 • Zacks Commentary
NEUTRAL
Down 16.9% in 4 Weeks, Here's Why Conmed ( CNMD ) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Conmed (CNMD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Nov 13, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Is CONMED ( CNMD ) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Nov 11, 2025 • Zacks Commentary
BULLISH
Conmed ( CNMD ) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nov 10, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Wall Street Analysts Think Conmed ( CNMD ) Could Surge 25.54%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Conmed (CNMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Nov 10, 2025 • Zacks Commentary
BULLISH
Here's Why Conmed ( CNMD ) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Nov 07, 2025 • Zacks Commentary
BULLISH
CNMD or MMSI: Which Is the Better Value Stock Right Now?
CNMD vs. MMSI: Which Stock Is the Better Value Option?